To improve the quality of care for nursing home residents, researchers at Indiana University have translated their research into practice through a startup called Probari. The health care services startup was developed by Kathleen Unroe, a professor of medicine at the IU School of Medicine and a research scientist at the IU Center for Aging… Read more »
Entries by Bri Heron
IU Kelley School of Business course introduces students to the life sciences industry, potential career opportunities
Indiana University Bloomington students are diving into the life sciences industry by learning about its complexities and intricate network of relationships that aid in bringing innovative health solutions to market. The IU Innovation and Commercialization Office is a sponsor of a course offered by the IU Kelley School of Business, “Life Sciences from Research to… Read more »
IU researcher receives award to advance development of new therapeutic to combat HIV-1 latency
To advance faculty research and enhance the commercialization of Indiana University innovations, the IU Innovation and Commercialization Office has awarded the Lawrence Blatt Endowed Fund for Translational Research to Adarsh Dharan, an assistant professor of biology at IU Bloomington. The Lawrence Blatt Endowed Fund for Translational Research is designed to support the development of translational… Read more »
IU-developed training for advance care planning helps nursing home facilities honor patients’ wishes
Anyone could be faced with unexpected medical conditions, unable to communicate their health care decisions, so it is important to have plans in place ahead of time to ensure a patient’s wishes are being honored—particularly in a nursing home setting. With the online training they developed specifically for nursing home staff, Susan Hickman and her… Read more »
IU researcher develops new nanoparticle to help combat drug-resistant infections
Antimicrobial resistance has become a major global public health emergency that accounts for 2.8 million infections per year according to the U.S. Centers for Disease Control and Prevention. Despite new and existing antibiotics on the market, the antimicrobial resistance is outpacing the development, making the need for new antimicrobial treatments a growing priority. Yan Yu,… Read more »
IU faculty startup MBX Biosciences announces $163.2 million U.S. IPO
MBX Biosciences, an Indiana University faculty-created startup that develops peptide therapies for the treatment of endocrine and metabolic diseases, raised $163.2 million in its U.S. initial public offering. The company’s peptides are based on chemistry developed by a research team led by Richard DiMarchi, scientific cofounder of MBX Biosciences and Distinguished Professor of Chemistry in… Read more »
Patents awarded to three IU health innovations
Three Indiana University-led research innovations, designed to improve the treatment of Alzheimer’s disease and ovarian and other cancers, recently received patents from the U.S. Patent and Trademark Office. Below is information about each patent. Patent issued to small molecule inhibitors of ALDH for the treatment of epithelial ovarian cancer: The U.S. Patent and Trademark Office… Read more »
IU researcher develops therapies for severe asthma
Asthma affects 8 percent of the U.S. population. Severe asthma—the symptoms of which are difficult to manage despite high doses of medicines, like corticosteroids—accounts for most healthcare costs due to its complexity to treat. New therapies are needed to eliminate symptoms of this life-threatening disease. Ben Gaston, the Billie Lou Wood Professor of Pediatrics at… Read more »
Patents awarded to four IU innovations
Four Indiana University-led technologies and methods, spanning the fields of electrical engineering, medicine and music, recently received patents from the U.S. Patent and Trademark Office. Below is information about each patent. Patent issued to IU innovation method for treating clinical conditions through the use of hematopoietic stem cells: The U.S. Patent and Trademark Office has… Read more »
IU researcher develops anticounterfeit tags and environmental sensors using nanoparticles
From apparel to pharmaceuticals, the global impact of counterfeit goods can reach up to $1.7 trillion annually across numerous markets. To tackle this important issue, Indiana University research chemist Sara Skrabalak is using nanoparticles to develop anticounterfeit tags and environmental sensors that mark critical components to confirm if an item has been tampered with. She… Read more »